CBX-12 is a peptide drug conjugate (PDC) that targets tumors in an antigen-independent manner and exhibits antitumor activity. Comprising a pH-sensitive peptide (pHLIP), an auto-cleavable linker, and the topoisomerase 1 (TOP1) inhibitor Exatecan, it effectively targets cancerous cells.
Molecular Weight:
3629.05
Formula:
C169H240FN35O49S2
* VAT and and shipping costs not included. Errors and price changes excepted
